TAK-442, a direct factor Xa inhibitor, inhibits monocyte chemoattractant protein 1 production in endothelial cells via involvement of protease-activated receptor 1 - Shinozawa, E; Nakayama, M; Imura, Y (Front Pharmacol, 2018)